Mylan And Biocon's Insulin May Get US Reprieve

Insulin Glargine Application Would Get Respite Under US Budget Legislation

 
• By Cathy Kelly
Syringe
A potentially valuable application is on the line for Mylan and Biocon • Source: Shutterstock

More from Policy & Regulation

More from Generics Bulletin